Authors: Woodrum, DL

Citation: Dl. Woodrum, Suddenly out of the field, part II: Dos and don'ts of moving on, J HEALTHC M, 46(6), 2001, pp. 369-379

Authors: Woodrum, DL

Citation: Dl. Woodrum, Suddenly out of the field, part I: The story, J HEALTHC M, 46(5), 2001, pp. 301-312

Authors: Gelmann, EP Chia, D Pinsky, PF Andriole, GL Crawford, ED Reding, D Hayes, RB Kramer, BS Woodrum, DL Gohagan, JK Levin, DL

Citation: Ep. Gelmann et al., Relationship of demographic and clinical factors to free and total prostate-specific antigen, UROLOGY, 58(4), 2001, pp. 561-566

Authors: Partin, AW Catalona, WJ Finlay, JA Darte, C Tindall, DJ Young, CYF Klee, GG Chan, DW Rittenhouse, HG Wolfert, RL Woodrum, DL

Citation: Aw. Partin et al., Use of human glandular kallikrein 2 for the detection of prostate cancer: Preliminary analysis, UROLOGY, 54(5), 1999, pp. 839-845

Authors: Catalona, WJ Partin, AW Finlay, JA Chan, DW Rittenhouse, HG Wolfert, RL Woodrum, DL

Citation: Wj. Catalona et al., Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: An alternative model, UROLOGY, 54(2), 1999, pp. 220-224

Authors: Chan, DW Kelley, CA Ratliff, TL D'Agostino, D Ritchey, J Lamb, DJ Beck, J Lott, N Wener, MH Daum, P Henkin, RE Kaske, DN Golightly, DW McBride, J Layco, G Ota, MK Tanasijevic, MJ Grudzien, C Woodrum, DL Bray, KR Southwick, PC Gasior, GH Loveland, KG

Citation: Dw. Chan et al., Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine theclinical utility of percentage of free prostate-specific antigen, CLIN CHEM, 45(10), 1999, pp. 1863-1865